Our Fund
We invest in biotech startups developing platform technologies or therapeutics for rare or overlooked diseases. Our ethos is to support founders with our team & tech to help them bring medicines to patients.
Great programs.
Great people.
Great potential.
We are therapeutic area and modality agnostic. We’re not afraid to be early to help fund & guide high-potential drug programs through value inflection points.
Tech is our competitive advantage.
With the power of AI, our team quickly and comprehensively diligences therapeutics. Vibe portfolio founders also benefit from value-added analyses, like competitive benchmarking, R&D planning, and risk assessments.
We are deeply appreciative of our partnership with Vibe Bio. The team went above-and-beyond for us on multiple fronts. Vibe helped us raise an oversubscribed round and has provided unparalleled development expertise. Eigen is thrilled to have a strong cap table to transform cancer treatments for patients worldwide.
